The Demographics of Aging and Its Impact on the Cardiovascular Health

Current Cardiovascular Risk Reports

Volumn 9, Issue 4, 2015, Pages

  Azhar, Gohar ^a   Wei, Jeanne Y ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Aging; Cardiovascular; Demographics

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; AGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY DISEASE; DEMOGRAPHY; EMPLOYMENT STATUS; GERIATRIC PATIENT; HEALTH CARE COST; HEALTH STATISTICS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PATIENT EDUCATION; PHYSICAL DISABILITY; POPULATION DISTRIBUTION; POPULATION GROWTH; REVIEW; SICK SINUS SYNDROME; UNITED STATES;

EID: 84922982870     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-015-0441-x     Document Type: Review

References (39)

1. Kulminski AM, Culminskaya I. Genomics of human health and aging. Age. 2011;35(2):455–69.
2. Barzilai N, Atzmon G. Genes for exceptional longevity. Annu Rev Gerontol Geriatr. 2014;34(1):171–88. This study provides a comprehensive overview of genes associated with longevity in lower species as well as human centenarians.
3. Zhang X, Azhar G, Wei JY. The expression of microRNA and microRNA clusters in the aging heart. PLoS One. 2012;7(4):e34688. This article discusses the impact of microRNA clusters in the adult mouse heart during aging as well as the role of individual microRNAs and Argonaut proteins.
4. Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev. 2008;88:557–79.
5. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013;75:685–705.
6. Katada S, Imhof A, Sassone-Corsi P. Connecting the threads: epigenetics and metabolism. Cell. 2012;148(1–2):24–8.
7. Flatt T, Schmidt PS. Integrating evolutionary and molecular genetics of aging. Biochim Biophys Acta. 2009;1790(10):951–62.
8. Rogers SC, Zhang X, Azhar G, Luo S, Wei JY. Exposure to high or low glucose levels accelerates the appearance of markers of endothelial cell senescence and induces dysregulation of nitric oxide synthase. J Gerontol A Biol Sci Med Sci. 2013;68:1469–81.
9. Rossi DJ, Jamieson CHM, Weissman IL. Stems cells and the pathways to aging and cancer. Cell. 2008;132(4):681–96.
10. Haigis MC, Yankner BA. The aging stress response. Mol Cell. 2010;40(2):333–44.
11. Odiet JA, Wei JY. Heart failure and the aging myocardium: possible role of cardiac mitochondria. Heart Fail Rev. 1996;2:139–49.
12. Wei JY. Age and the cardiovascular system. N Engl J Med. 1992;327:1735–9.
13. Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42(7):1226–33.
14. The State of Aging and Health in America. Centers for Disease Control and Prevention. Atlanta: Centers for Disease Control and Prevention, US Dept of Health and Human Services; 2013. This article provides a snapshot of the aging landscape in the United States with the most current information and statistics.
15. Atchley RC. Retirement as a social institution. Annu Rev Sociol. 1982;8:263–87.
16. Older Americans. Key indicators of well-being. U.S. Federal Interagency Forum on Aging Related Statistics (FIFARS) with the U.S. National Center for Health Statistics (NCHS). Washington, DC: U.S. Federal Interagency Forum on Aging Related Statistics; 2012.
17. Aging America. Trends and projections. An information paper to the Special Committee on Aging, United States Senate, Nov 1989, serial no. 101-E. U.S. Government Printing Office, 1989.
18. Hogan C, Lunney J, Gabel J, Lynn J. Medicare beneficiaries’ costs of care in the last year of life. Health Aff. 2001;20:188–95.
19. National Center for Health Statistics, National Vital Statistics Reports 2001;49(12).
20. Hoffman C, Rice D, Sung HY. Persons with chronic conditions: their prevalence and costs. JAMA. 1996;276(18):1473–9.
21. Wolf JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–76.
22. Meeting the needs of older adults with serious illness. Book Chapter. Shannon Brownlee, Christine Cassel, Vikas Saini. When more is less: overuse of medical services harms patients. Aging Med. 2014;3–18
23. Morgan SG. Prescription drug expenditures and population demographics. Health Serv Res. 2006;41:411–28.
24. Goldman DP, Cutler D, Rowe JW, Michaud P-C, Sullivan J, Peneva D, et al. Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff. 2013;32(10):1698–705.
25. Howard K, Koh A. 2020 Vision for Healthy People. N Engl J Med. 2010;362:1653–6. This guide describes the new health indicators and focus areas for health improvement for 2020, based on achievements and failures of the 2010 goals.
26. Martini EM, Garrett N, Lindquist T, Isham GJ. The boomers are coming: a total cost of care model of the impact of population aging on health care costs in the United States by major practice category. Health Serv Res. 2007;42(1):201–18.
27. Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K. The impact of the aging population on coronary heart disease in the United States. Am J Med. 2011;124:827–33. A summary of the incidence, prevalence, mortality and costs of aging on coronary heart disease and its impact on the stakeholders.
28. Kitzman DW, Michael W. Rich age disparities in heart failure research. JAMA. 2010;304(17):1950–1.
29. Bhatia RS et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355:260–9.
30. Bhuiyan T, Maurer M. Heart failure and preserved ejection fraction: persistent diagnosis, therapeutic enigma. Curr Cardiovasc Risk Rep. 2001;440–9.
31. Yamada S, Shimizi Y, Suzuki M, Izumi T. Functional limitations predict the risk of rehospitalization among patients with chronic heart failure. Circ J. 2012;76:1654–61. The study highlights the importance of measuring function in heart failure patients to reduce the cost of rehospitalization and improve the overall prognosis.
32. Azhar G, Wei JY. New approaches to treating cardiac cachexia in the older patient. Curr Cardiovasc Risk Rep. 2013;7(6):480–4.
33. Jugdutt BI. Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail Rev. 2010;15:401–5.
34. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics—2010 update: a report from the American Heart Association statistics committee and stroke statistics sub-committee. Circulation. 2010;121:e1–170.
35. Rodgers GP, Conti JB, Feinstein JA, et al. ACC 2009 survey results and recommendations addressing the cardiology workforce crisis: a report of the ACC Board of Trustees Workforce Taskforce. J Am Coll Cardiol. 2009;54:1195–208.
36. Sinnaeve P R, Brueckmann M, Clemens A, Oldgren J, Eikelboom J, Healey J S. Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation. J Intern Med. 271(1) 15–24.
37. McEvoy JW, Nasir K. ABI and stroke: action at a distance and call to action. Atherosclerosis. 2014;234(1):73–4.
38. Lin P-J, Yang Z, Fillit HM, Cohen JT, Neumann PJ. Unintended benefits: the potential economic impact of addressing risk factors to prevent Alzheimer’s disease. Health Aff. 2014;33(4):547–54.
39. Maclay JD, MacNee W. Cardiovascular disease in COPD. Chest. 2013;143(3):798–807.